Clinical sign | Number of animals (% of all reported non-cutaneous AFR) | Strength of evidence |
---|---|---|
25–49a (28–55%) | Moderate in 14–33 [5, 7, 27,28,29,30,31] Weak in 1 [51] | |
26–46a (29–52%) | ||
3–20a (3–22%) | Strong in 1 [7] Moderate in 1 [4] Weak in 1–18 [46] | |
Salivating [46] | 1–18 (1–20%) | Weak |
Respiratory signs [7] | 4 (4%) | Moderate |
Flatulence [5] | 3 (3%) | Moderate |
Hyperactive behaviour [6] | 1 (1%) | Strong |